Introduction Declan OBrien Chairman Executive Board European Technology Platform for Global Animal H

1
IntroductionDeclan OBrienChairmanExecutive
BoardEuropean Technology Platform for Global
Animal Health (ETPGAH)
2
Logistics

• Present Strategic Research Agenda (SRA)
• Presentations by Chapter
• Focus on Recommendations
• Do you agree with Recommendations?
• If not, what are Alternatives?
• Any Ideas on Implementation?

3
Aim of ETPGAH

• To facilitate and accelerate the development and
  distribution of the most effective tools for
  controlling animal diseases of major importance
  to Europe and the rest of the world, thereby
  improving human and animal health, food safety
  and quality, animal welfare, and market access,
  contributing to achieving the Millennium
  Development Goals.

4
Organisation Chart - 1
5
Organisation Chart - 2

• The Steering Council (SC) is at the core of the
  ETPGAH. It is a network connecting the platform
  to the major stakeholders and the pool of ideas.
  The membership of the SC shall not exceed 30
  members. The Commission attends as observers.
• The Executive Board (EB) comprises 7 members
  selected from industry, users, and public bodies.
  The chair is be held by IFAH-Europe. There are
  observers from the Commission as necessary.
• A Stakeholder Forum is essential as the active
  and committed involvement of all the stakeholders
  is vital to the success and credibility of any
  Technology Platform. The forum is
  multi-disciplinary including industry, public and
  private research institutions, universities,
  public authorities, livestock, producers, civil
  society, consumers, funding bodies, third
  countries, international organizations (e.g. OIE,
  FAO, ) and International Research Institutes
  (e.g. ILRI).

6
Deliverables - 1

• Protect Europe from the incursion of epidemic
  animal diseases and zoonoses.
• Deal rapidly and effectively with disease
  outbreaks in Europe should they occur.
• Assist in speed of access to market, facilitation
  or world trade and the alleviation of poverty by
  reducing the impact of these diseases in
  developing countries. Reduce worldwide levels of
  disease and thereby indirectly protect Europe
  from disease spread by people or trade.

7
Deliverables - 2

• Bring more focus into research.
• Increase the translation of technology into
  applications.
• Bring the developed tools faster to the market.
• Explore legal and regulatory hurdles.
• Enable authorities to provide a swift and
  efficient reaction to new disease outbreaks.
• Ensure consumer safety and efficiency in product
  development.
• Explore feasibility, applicability, need and
  availability of existing products.

8
Strategic Research Agenda (SRA) - 1

• Reflect  Vision 2015  publication
• Prioritise Research
• Aware of Community Animal Health Policy
• Vaccines, Pharmaceuticals, Diagnostics
• Research, Technology Transfer, Horizontal Issues

9
Strategic Research Agenda (SRA) - 2

• To prioritise animal diseases
• To conduct a number of gap analyses
• To ensure high quality relevant fundamental
  research
• To identify the enabling factors to improve the
  rate of technology transfer
• To consider regulatory issues
• To maintain a global perspective